536 related articles for article (PubMed ID: 22858156)
1. Mechanisms of glioma-associated neovascularization.
Hardee ME; Zagzag D
Am J Pathol; 2012 Oct; 181(4):1126-41. PubMed ID: 22858156
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.
Plate KH; Scholz A; Dumont DJ
Acta Neuropathol; 2012 Dec; 124(6):763-75. PubMed ID: 23143192
[TBL] [Abstract][Full Text] [Related]
3. Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.
Groblewska M; Mroczko B
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200145
[TBL] [Abstract][Full Text] [Related]
4. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
5. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.
Mahase S; Rattenni RN; Wesseling P; Leenders W; Baldotto C; Jain R; Zagzag D
Am J Pathol; 2017 May; 187(5):940-953. PubMed ID: 28284719
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in gliomas: biology and molecular pathophysiology.
Fischer I; Gagner JP; Law M; Newcomb EW; Zagzag D
Brain Pathol; 2005 Oct; 15(4):297-310. PubMed ID: 16389942
[TBL] [Abstract][Full Text] [Related]
8. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
9. Tumor vasculature and glioma stem cells: Contributions to glioma progression.
Jhaveri N; Chen TC; Hofman FM
Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451
[TBL] [Abstract][Full Text] [Related]
10. Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.
Dong J; Zhao Y; Huang Q; Fei X; Diao Y; Shen Y; Xiao H; Zhang T; Lan Q; Gu X
Stem Cell Rev Rep; 2011 Mar; 7(1):141-52. PubMed ID: 20697979
[TBL] [Abstract][Full Text] [Related]
11. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
[TBL] [Abstract][Full Text] [Related]
13. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
14. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.
Anderson JC; Grammer JR; Wang W; Nabors LB; Henkin J; Stewart JE; Gladson CL
Cancer Biol Ther; 2007 Mar; 6(3):454-62. PubMed ID: 17384534
[TBL] [Abstract][Full Text] [Related]
15. Vasculogenic mimicry: a novel target for glioma therapy.
Chen YS; Chen ZP
Chin J Cancer; 2014 Feb; 33(2):74-9. PubMed ID: 23816560
[TBL] [Abstract][Full Text] [Related]
16. Adhesion molecules and the extracellular matrix as drug targets for glioma.
Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Argyriou AA; Giannopoulou E; Kalofonos HP
Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
Miletic H; Niclou SP; Johansson M; Bjerkvig R
Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
[TBL] [Abstract][Full Text] [Related]
19. MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.
Seshadri M; Ciesielski MJ
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1373-82. PubMed ID: 19458603
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis as a therapeutic target in malignant gliomas.
Chi AS; Sorensen AG; Jain RK; Batchelor TT
Oncologist; 2009 Jun; 14(6):621-36. PubMed ID: 19487335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
